Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study
- François Rannou
- Lucille Desallais
- Christelle Nguyen
- Camille Daste
- Quentin Kirren
- Marie-Martine Lefevre-Colau
- Odile Launay
- Hadley Mouhsine
- Barbara Ruiz
- Gabriel Moreau
- Florent Langenfeld
- Edita Dolimier
- Hervé Do
- René Azoulai
- Francis Berenbaum
- Marie-Christophe Boissier
- Jean-Pierre Salles
- Jean-François Zagury
2025-11-05